StockData
Guardant Health, Inc. logo

Guardant Health, Inc. (GH) stock

GHNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$143.28−0.75 (-0.52%)

Close on Nov 17, 2026Market cap $19.23BP/E –Yield –

Guardant Health price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Guardant Health's price to book ratio was 62.7× on Jul 31, 2024, against 38.5× a year earlier. Over the last 5 years it ranged from 7.3× to 62.7×, with a median of 13.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jul 31, 202462.7×+48.7
2023Dec 29, 202314.0×−2.7
2022Dec 30, 202216.7×+2.4
2021Dec 31, 202114.3×+2.5
2020Dec 31, 202011.8×+2.8
2019Dec 31, 20199.0×+7.1
2018Dec 31, 20181.9×–

More Guardant Health figures

See a number that looks wrong?